Work rehabilitation for women recovering from breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on supporting women with breast cancer to return to work after treatment. It utilizes an online self-management program called CanWork, which was developed in collaboration with cancer survivors and healthcare professionals. The program aims to help participants manage health-related difficulties and understand their workplace entitlements. By addressing the physical and psychological challenges faced by these women, the intervention seeks to enhance their quality of life and work outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women with confirmed diagnosis of breast cancer
* Women with breast cancer who were in paid employment prior to their cancer diagnosis
* Women with breast cancer who have completed adjuvant oncology treatment (excluding hormone therapy, targeted and biological therapies) within the last 12 months
* Women with breast cancer who have capacity to participate in a six-week online occupational therapy intervention

Exclusion Criteria:

* Women with metastatic breast cancer
* Women with breast cancer who were not in paid employment prior to their cancer diagnosis
* Women with breast cancer who have decided not to return to work following completion of cancer treatment
* Women with breast cancer who have co-morbidity that would interfere with capacity to participate in a six-week online occupational therapy intervention

Where it's running

• Cancer Care West
  Galway, Ireland Recruiting
• Solas Cancer Support Centre
  Waterford, Ireland Recruiting

Study contacts

• Principal investigator: Deirdre Connolly, PhD — University of Dublin, Trinity College
• Study coordinator: Deirdre Connolly, PhD
• Email: connoldm@tcd.ie
• Phone: 018963216

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.